Please ensure Javascript is enabled for purposes of website accessibility

Health Systems Node – NIDA Clinical Trials Network


The goals of the Health Systems Node (HSN) of the National Institute on Drug Abuse Clinical Trials Network are to improve access to care for the many people whose substance use/substance use disorder (SU/SUDs) are unrecognized, overlooked, and/or untreated and to improve acceptability of SUD treatment, thereby reaching more people.

The long-term vision is for health systems to address all patients’ SU/SUDs in an integrated, effective manner and to offer a range of innovative interventions. The HSN research agenda is focused on identifying effective practices for patients with substance use/substance use disorders, designing and testing sustainable ways to integrate those practices into medical care, and developing and disseminating high quality methods to support this research.


Mission, Vision, and Values

  • MISSION: To improve screening and treatment of people suffering from substance use disorders and the understanding and management of substance use disorders through a closer connection between research, practice, and policy.

  • VISION: Identify research questions that matter to patients, healthcare providers, and health systems, effiiciently answer those questions involving real-world patients and providers, and disseminate and implement research results. 

  • VALUES: As part of the larger NIDA Clinical Trials Network, we share the values of scientific excellence, innovation and creativity, actionable research findings, collaboration and teamwork, transparency, and efficiency.

  • Funding agency: National Institute on Drug Abuse (NIDA)

  • Year funded: 2016

Primary Investigators

Cynthia Campbell, PhD, MPH

Katharine Bradley, KPWA


Steering Committee Members

  • Co-Chair: Kevin High, MD of Wake Forest University (OAIC)
  • Co-Chair: Eric Larson, MD, MPH of Group Health Research Institute (HCSRN)
  • Thomas Gill, MD of Yale (OAIC)
  • Alan Go, MD of Kaiser Permanente Northern California’s Division of Research (HCSRN)
  • Susan Greenspan, MD of the University of Pittsburgh (OAIC)
  • Leah Hanson, PhD of HealthPartners (HCSRN)
  • Mark Hornbrook, PhD of Kaiser Permanente’s Center for Health Research (HCSRN)
  • Rebecca Silliman, MD, PhD of Boston University (OAIC)
  • Ming Tai-Seale, PhD, MPH of Palo Alto Medical Foundation Research Institute (HCSRN)
  • Heather Whitson, MD, MHS of Duke University (OAIC)

Advisory Committee Members

  • Cynthia Boyd, MD, MPH of Johns Hopkins University School of Medicine
  • Mary Naylor, PhD, MSN, RN, FAAN of the University of Pennsylvania School of Nursing
  • Linda Teri, PhD of the University of Washington School of Nursing
  • Mary Tinetti, MD of Yale School of Med

Relevant Publications

E Bayliss*, D Bonds, C Boyd*, M Davis, B Finke, M Fox, R Glasgow, R Goodman, S Heurtin-Roberts, S Lachenmayr,  C Lind, E Madigan, D Meyers, S Mintz, W Nilsen, S Okun, S Ruiz, M Salive*, K Stange. Annals of Family Medicine. 2014 Jan. 12(3):260-9.

*Investigators affiliated with the HCSRN-OAICs AGING Initiative